The presentation of the 2021 BioRegion of Catalonia Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, will take place on January 26 in hybrid format *: in person at the AXA Auditorium in Barcelona and will also be streamed. The report is promoted by Biocat, together with CataloniaBio & HealthTech and ACCIÓ.

In addition to the presentation of the main indicators and results from the report, we’ll also have two panel discussions to share experiences from benchmark countries in regulatory issues and speak about the BioRegion’s commitment to becoming a hub for advanced therapies and precision medicine.

How have the main health innovation indicators evolved this year of the pandemic? Has more been invested than last year? How is Catalonia positioned on the stock markets? What should be taken into account in putting together an international market access strategy? Save your spot and find it out.

10:00 am  Institutional  Welcome

• The Hon. Pere Aragonès, President of the Government of Catalonia

10:15 am Presentation of the 2021 BioRegion Report

• Robert Fabregat, CEO, Biocat
• Jaume Amat, President, CataloniaBio & HealthTech / Silvia Ondategui, Partner Life Sciences, Ernst & Young
• Natàlia Mas, Director General of Industry, Government of Catalonia, and CEO of Catalonia Trade & Investment

11:00 am  Networking (outdoors)

11:45 am Round table: “Hi, I’m an SME, where is my fast track?”
Chair: Montserrat Daban, Scientific and International Relations Director of Biocat

• Healthcare marketplace: a go-to market strategy across Europe  – Richard Charter, Vice President, Market Access MedTech Europa and Asia-Pacific at Alira Health
• The DiGA Fast Track, enabling digital transformation – Marco Wendel, CEO at Medical Valley Digital Health Application Center GmbH
• Transposing the DiGA to the French market (challenges & opportunities) – Nina Bufi, eHealth Projects Director at French Ministry of Health
• The route to procurement in the UK and overseas  –  Suzanne Ali-Hassan, Deputy Director, Commercial & Innovation at UCL Partners
• The five keywords of value-based procurement – Ramon Maspons, CIO at Agency for Health Quality and Assessment of Catalonia (AQuAS)

12:45 am The Next Generation bet for the BioRegion: the new advanced therapies and precision medicine hub
Chair: Robert Fabregat, CEO, Biocat

• Mariona Sanz, Managing Director of European Funds, Goverment of Catalonia
• Fina Lladós, CEO, AMGEN
• Toni Andreu, Scientific Director, EATRIS
• Joan Comella, Secretary of ACER (Catalan Association of Research Entities))

• Ignasi Biosca, CataloniaBio & HealthTech and CEO ReigJofre 

13:15 pm Closing 

• Robert Fabregat, CEO, Biocat

13:30 pm  Networking (outdoors)

* IMPORTANT NOTE: This event is scheduled to be held at the AXA Auditorium (Barcelona) if the situation and the Covid measures in place at that date allow it. Following the current protocol and security measures, you will be asked for the Covid passport (digitally or on paper) or a negative PCR / antigen test to access the event, as well as your ID or identification document. We recommend that you arrive early to avoid crowds.

Related information:

• Report: Investment in health startups in Catalonia tops €200 million again in 2021
• BioRegion of Catalonia Report

Organizers:

In collaboration with:

With the support of: